💨 Abstract

The article provides a financial update on Ironwood Pharmaceuticals Inc. (IRWD) for the first quarter of 2025. The company reported a net loss of $37.4 million, or 23 cents per share, which exceeded the adjusted loss of 14 cents per share. These results fell short of Wall Street's expectations, with analysts predicting a loss of 5 cents per share. Additionally, the company's revenue of $41.1

Courtesy: wtop.com

Summarized by Einstein Beta 🤖